ABSTRACT
This article describes a case of intra-abdominal desmoplastic small round cell tumor(DSRCT) experienced by the authors. The patient was 36ear old male, and admitted because of the mass of right inguinal area, back pain, weakness of low extremities. Imaging studies, right inguinal mass biopsy finding, immunohistochemical stains were compatible with DSRCT. Aggressive treatment with chemotherapy resulted in remarkable response temporarily in terms of tumor size and pulmonary metastasis. But as other author`s reports, multiple metastases to brain, spine, lung were progressed in our case. The patient died 13months after diagnosis.
Subject(s)
Humans , Male , Back Pain , Biopsy , Brain , Coloring Agents , Diagnosis , Drug Therapy , Extremities , Lung , Neoplasm Metastasis , SpineABSTRACT
Typhoid fever is an acute systemic febrile disease caused by Salmonella Typhi, characterized by persistent fever, headache, abdominal pain, diarrhea and rose spots. Salmonella infection can lead to diffuse organ involvement including bone, lung, thyroid, kidney, liver, spleen, heart, intestine and skin. While a variety of complications may be seen in typhoid fever, sensorineural hearing loss or pancreatitis has been rarely observed. Recently, we experienced a case of typhoid fever complicated by sensorineural hearing loss, acute pancreatitis and hepatitis in a 21-year-old female patient, who was improved with ceftriaxone and ciprofloxacin administration and supportive care. We report this case with a review of the literature.
Subject(s)
Female , Humans , Young Adult , Abdominal Pain , Ceftriaxone , Ciprofloxacin , Diarrhea , Fever , Headache , Hearing Loss, Sensorineural , Heart , Hepatitis , Intestines , Kidney , Liver , Lung , Pancreatitis , Salmonella Infections , Salmonella typhi , Skin , Spleen , Thyroid Gland , Typhoid FeverABSTRACT
PURPOSE: We investigated the usefulness of urinary pyridinoline (uPyr) and deoxypyridinoline (uDpyr) and serum osteocalcin as markers of bone metastasis, particularly focussing on quantitative correlation between the degree of bone metastasis and the level of biochemical markers. MATERIALS AND METHODS: By using ELISA method we measured the levels of uPyr, uDpyr, and osteocalcin in 100 cancer patients of whom 58 patients had bone metastasis, 42 had no bone metastasis, and 44 control subjects. RESULTS: There was a significant difference in uPyr level between the patients with bone metastasis and the patients without bone metastasis or control group (mean+/-SD, 70.26+/-43.11 vs 38.93+/-21.48 or 25.13+/-8.81 nM/mM Creatinine, p<0.05). And uDpyr level showed more significant elevation in the patients with bone metastasis than in the patients without bone metastasis and in control group (12.63+/-7.51 vs 6.44+/-3.58 and 4.23+/-1.70 nM/mM Creatinine p<0.05). Osteocalcin level showed no significant difference among groups. We could demonstrate a significant quantitative correlation between the extent of bone metastasis and the amount of uPyr (r=0.7482, p<0.001) or uDpyr (r=0.5992, p<0.001). CONCLUSION: uPyr and uDpyr were significantly increased in metastatic bone tumors and quantitatively correlated well with the extent of bone metastasis. Therefore we can use these two markers as an evidence of bone metastasis. Further studies are recommended to decide the usefulness of these markers in the early detection of bone metastasis and in the assessment of response to antiresorptive treatments.